PAVM PAVmed Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PAVM

Price (delayed)

$5.695

Market cap

$41.42M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$37.65

Enterprise value

$51.97M

?
Relative Growth: Rel. Growth: 2
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 2

PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital ...

Highlights
PAVmed's revenue has plunged by 96% YoY but it has increased by 20% from the previous quarter
PAVM's gross profit has surged by 83% year-on-year but it is down by 31% since the previous quarter
The net income has dropped by 125% year-on-year
The EPS has dropped by 119% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.pavmed.com
Peers: OBIO OM

Key stats

What are the main financial stats of PAVM

PAVM stock price

How has the PAVmed stock price performed over time
Intraday
-2.4%
1 week
-9.17%
1 month
-29.95%
1 year
-69.05%
YTD
-13.97%
QTD
-43.89%

Financial performance

How have PAVmed's revenue and profit performed over time
Revenue
$85,000
Gross profit
-$193,000
Operating income
-$24.4M
Net income
-$18.63M
Gross margin
-227.1%
Net margin
-21,914.1%
The net income has dropped by 125% year-on-year
PAVmed's revenue has plunged by 96% YoY but it has increased by 20% from the previous quarter
PAVM's gross profit has surged by 83% year-on-year but it is down by 31% since the previous quarter
PAVM's operating income is up by 32% year-on-year but it is down by 12% since the previous quarter

Price vs fundamentals

How does PAVM's price correlate with its fundamentals

Growth

What is PAVmed's growth rate over time

Valuation

What is PAVmed stock price valuation
PAVM P/E details
P/E
N/A
P/B
0.92
P/S
105.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
611.39
The EPS has dropped by 119% year-on-year
The stock's price to book (P/B) is 57% more than its last 4 quarters average of 0.6
The equity is up by 16% since the previous quarter but it has declined by 12% year-on-year
PAVmed's revenue has plunged by 96% YoY but it has increased by 20% from the previous quarter
The stock's price to sales (P/S) is 60% less than its 5-year quarterly average of 274.6 and 25% less than its last 4 quarters average of 145.6

Efficiency

How efficient is PAVmed business performance
PAVM's return on assets has dropped by 136% year-on-year
The company's return on invested capital has shrunk by 118% YoY

Dividends

What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PAVM.

Financial health

How did PAVmed financials performed over time
The total assets is 122% more than the total liabilities
The total liabilities has surged by 72% year-on-year and by 24% since the previous quarter
The total assets has grown by 17% from the previous quarter but it has contracted by 14% YoY
The debt is 57% less than the equity
PAVM's debt to equity has surged by 105% year-on-year and by 10% since the previous quarter
The debt has soared by 84% YoY and by 27% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.